Fiche du document
- handle: 10670/1.ffjolr
- hal: hal-03460243
- SCIENCESPO: 2441/7l4jckplm384p8nvmrb87e4cdm
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/hdl/2441/7l4jckplm384p8nvmrb87e4cdm
info:eu-repo/semantics/OpenAccess
Mots-clés
Clinical trials Masculinity Stem cells Heart diseaseSujets proches
Progenitor cells Mother cells Colony-forming units (Cells) Ageing Senescence Age--Physiological effectCiter ce document
Annette Leibing et al., « Participating in clinical trials: masculinity, stem cells and heart disease », Archive ouverte de Sciences Po (SPIRE), ID : 10670/1.ffjolr
Métriques
Partage / Export
Résumé
One of the ways to understand the many trajectories of aging is to focus on individuals who have, for a variety of reasons, enjoyed privileged access to health care and are therefore able to envisage an aging process that would not otherwise have been possible. This article is based on interviews conducted with men aged 53 to 77, living in a major Canadian city, who suffered serious heart incidents and subsequently took part in a clinical trial program involving the use of stem cells. As a result of their participation in this program, these men have new hope for the future, are able to make concrete plans and can entertain the possibility of aging “in good health.”